ERBB2 and breast cancer: Further, age is not the only important prognostic factor in BC, multiple previous studies have also highlighted the role of the BC molecular subtypes [6], with luminal subtypes having more favourable prognosis than triple negative BC (TNBC) or human epidermal growth factor receptor (HER2) enriched subtypes [7–12].